Ingegerd Wennerbeck, MSc, PhD, was the owner and managing director of Novecon Research AB, working as a consultant to the pharmaceutical industry for over 20 years. Before that she worked as Director of Research administration and Regulatory Affairs at Astra Draco in Lund. She has experience in project planning and in working with domestic as well as international marketing authorisation dossiers and liaisons with regulatory authorities world-wide. As a consultant in Regulatory Affairs and Clinical Research she has been involved in giving advice on regulatory strategy, documentation requirement and overall plans for studies in humans. Dr Wennerbeck has also worked with submitting dossiers for marketing approval and clinical trial clearance in the Scandinavian countries as well as designing study protocols, case record forms, performing and supervising monitoring work for different type of clinical studies. She has been engaged in in-house training and lecturing on clinical as well as regulatory strategy.

Dr Wennerbeck has published approximately 15 papers in the area of organic chemistry and 12 papers in the regulatory affairs area. Dr Wennerbeck is now working from her own company, Weteko Publisher AB, as a consultant to the pharmaceutical industry.